Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.1, 2006-01, pp. : 1-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine Shabaruddin Fatiha H

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite

Cost Utility of Tumour Necrosis Factor-α Inhibitors for Rheumatoid Arthritis: An Application of Bayesian Methods for Evidence Synthesis in a Markov Model

By Nguyen Christine M. Bounthavong Mark Mendes Margaret A.S. Christopher Melissa L.D. Tran Josephine N. Kazerooni Rashid Morreale Anthony P.

PharmacoEconomics, Vol. 30, Iss. 7, 2012-07 ,pp. : 575-593

Adis International

Access to resources Recommend Favorite

Estimating `Costs' for Cost-Effectiveness Analysis

By Miners Alec

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 745-751

Adis International

Access to resources Recommend Favorite

Subgroups and Heterogeneity in Cost-Effectiveness Analysis

By Sculpher Mark

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 799-806

Adis International

Access to resources Recommend Favorite

Exploring Uncertainty in Cost-Effectiveness Analysis

By Claxton Karl

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 781-798

Adis International

Access to resources Recommend Favorite